Eugene Pietzak, MD

Trials

Studies that name Eugene Pietzak, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:02 UTC. Open this list on ClinicalTrials.gov

• Ph3
  NCT07000084 · Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

  Alliance for Clinical Trials in Oncology · recruiting · Recurrent Non-Muscle Invasive Bladder Carcinoma, Stage 0a Bladder Cancer AJCC v8, Stage I Bladder Cancer AJCC v8 · study chair
• Ph3
  NCT06929286 · A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)

  Memorial Sloan Kettering Cancer Center · recruiting · Non-Muscle Invasive Bladder Cancer · principal investigator
• Ph2
  NCT04917809 · A Study of Oral Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer

  Memorial Sloan Kettering Cancer Center · active not recruiting · Bladder Cancer, Recurrent Bladder Cancer, FGFR3 Gene Mutation · principal investigator
• Ph1/Ph2
  NCT04179162 · Bacillus Calmette-Guérin (BCG) and Gemcitabine in People With High-Grade Non-Muscle Invasive Bladder Cancer That Came Back After BCG Treatment

  Memorial Sloan Kettering Cancer Center · active not recruiting · Non-Muscle Invasive Bladder Cancer (NMIBC) · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 10:02 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.